Quantcast

Latest Thyroid Stories

2014-05-13 08:31:36

SOUTH SAN FRANCISCO, Calif., May 13, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of its Afirma Malignancy Classifiers to further establish the Afirma Thyroid FNA Analysis as a comprehensive tool for reducing unnecessary surgeries and healthcare costs among the more than 525,000 U.S. patients each year who undergo fine needle aspiration (FNA) biopsies to rule out cancer in thyroid nodules. The Afirma Malignancy Classifiers comprise genomic tests for...

2014-05-07 08:32:27

SOUTH SAN FRANCISCO, Calif., May 7, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced that early data demonstrating the company's ability to develop a molecular classifier differentiating interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF), will be presented at the American Thoracic Society (ATS) 2014 International Conference taking place May 16-21, 2014 in San Diego. "We are excited to share our first proof-of-concept data for the development...

2014-05-06 08:34:15

SOUTH SAN FRANCISCO, Calif., May 6, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that four abstracts supporting the use of the company's Afirma Malignancy Classifiers and enhancing its overall Afirma solution will be presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific & Clinical Congress taking place May 14-18, 2014 in Las Vegas. Veracyte developed the Afirma Malignancy Classifiers to further expand the Afirma...

2014-05-02 08:24:46

SOUTH SAN FRANCISCO, Calif. and SAO PAULO, Brazil, May 2, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) and Fleury Medicine and Health today announced a new partnership that will make Veracyte's Afirma Gene Expression Classifier (GEC) available to patients in Brazil, helping to reduce unnecessary surgeries and potentially lower costs there as part of thyroid cancer diagnosis. Financial terms of the agreement were not disclosed. Through the agreement, Fleury, which has...

2014-05-01 08:35:55

SOUTH SAN FRANCISCO, Calif., May 1, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced today that its first quarter 2014 financial results will be released after close of market on Thursday, May 8, 2014. Following the announcement, Veracyte's management will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial results and provide a general business update. The live webcast and subsequent replay may be accessed by visiting...

2014-04-27 23:02:26

The Hypothyroidism Exercise Revolution created by Tom is a new program that gives people natural remedies, techniques, tips, and detailed instructions on how to treat their hypothyroidism easily. An overview on the website Vinaf.com shows if the program is good for people to use. Tampa, FL (PRWEB) April 27, 2014 The Hypothyroidism Exercise Revolution is a new program developed by Tom Brimeyer, who has many years of experience in studying hypothyroidism treatments. The program introduces...

2014-04-09 16:23:19

LONDON, April 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Thyroid Cancer Global Clinical Trials Review, H2, 2013Thyroid Cancer Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Thyroid Cancer Global Clinical Trials Review, H2, 2013" provides data on the Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thyroid Cancer. It includes an overview...

2014-04-07 23:28:50

Hypothyroidism Revolution program, developed by Tom Brimeyer, is a complete guide that teaches people how to get rid of their hypothyroidism condition naturally. A detailed review written by Henry Phan on the site Vkool.com reveals whether or not this program is worthy trying. Seattle, WA (PRWEB) April 07, 2014 Hypothyroidism Revolution program is created by Tom Brimeyer, who promises to help hypothyroidism sufferers cure their problem quickly without using any type of harmful drugs or...

2014-03-25 23:30:47

Thyromine, an industry leader in natural thyroid health, receives a best-in-class 5-star rating from TopConsumerReviews.com. Overland Park, KS (PRWEB) March 25, 2014 TopConsumerReviews.com recently awarded their highest five-star rating to Thyromine, an industry leader in thyroid health. “We’re pleased to receive TopConsumerReviews.com’s highest rating,” said Warren Brite, Sales Manager at Pacific Naturals, the maker of Thyromine. “We’re committed to helping our customers...

2014-03-11 08:29:14

SOUTH SAN FRANCISCO, Calif., March 11, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its fourth quarter and full-year 2013 financial results after close of market on Tuesday, March 18, 2014. Following the release, Veracyte will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial results and business progress. The live webcast and subsequent replay may be accessed by visiting Veracyte's website...


Latest Thyroid Reference Libraries

Thyroid And Parathyroid Glands
2013-03-04 13:34:45

The thyroid gland is an endocrine gland located anterior to the trachea and inferior to the thyroid cartilage. It is butterfly shaped with three lobes that make it the largest endocrine organ in the body. Its primary function is to control the body’s metabolism by regulating how quickly the body uses energy, proteins, and hormones. The two lateral lobes are connected by the middle lobe called the isthmus, which lies directly on top of the trachea. The entire gland is enclosed in a...

More Articles (1 articles) »
Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related